semaglutide cardiovascular outcomes 2025 news risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial semaglutide cardiovascular outcomes news 2025

US$ 27.78

★★★★★ 4.6 (14 reviews)

US$ 25.01

★★★★★ 5.0 (7 reviews)

US$ 24.55

★★★★★ 4.9 (7 reviews)

US$ 29.87

★★★★★ 4.0 (16 reviews)

US$ 24.88

★★★★★ 4.9 (17 reviews)

US$ 25.58

★★★★★ 5.0 (17 reviews)

US$ 28.16

★★★★★ 4.5 (14 reviews)

US$ 29.83

★★★★★ 4.4 (9 reviews)

US$ 22.11

★★★★★ 4.3 (27 reviews)

US$ 21.65

★★★★★ 4.4 (18 reviews)

US$ 25.38

★★★★★ 4.4 (10 reviews)

US$ 21.07

★★★★★ 4.9 (26 reviews)

US$ 24.01

★★★★★ 4.8 (9 reviews)

US$ 26.61

★★★★★ 4.5 (19 reviews)

US$ 25.54

★★★★★ 5.0 (9 reviews)

US$ 29.54

★★★★★ 5.0 (16 reviews)

US$ 28.44

★★★★★ 4.9 (10 reviews)

US$ 28.78

★★★★★ 4.6 (5 reviews)

US$ 22.34

★★★★★ 4.7 (16 reviews)

US$ 29.55

★★★★★ 4.4 (14 reviews)